• Boston University

Register for New Account

Register

Provide your credentials to log in
Remember Me Login

Forgot your password?

For core clinical content designed to help you safely and effectively manage patients with chronic pain, when appropriate, with opioid analgesics, please visit our sister site, SCOPE of Pain.

 

  1. Optimizing Office Systems
  2. Office Systems Safe and Competent Opioid Prescribing: Optimizing Office Systems Program CME Post-Test Evaluation
  1. Massachusetts Laws
  2. Educational Program Making Sense of Massachusetts Opioid Prescribing Laws and State and National Guidelines Program CME Post-Test Evaluation
  1. Dental Pain
  2. Educational Program Safe Opioid Prescribing for
    Acute Dental Pain
    Program CME Post-Test Evaluation
  1. Prescribe to Prevent
  2. Educational Program Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists Information Program CME Post-Test Evaluation
  1. Military Modules
  2. Module 1 Military SCOPE of Pain: Safe and Competent Opioid Prescribing For Providers Working with Veterans and Military Service Personnel Information Video CME Post-Test Evaluation
  3. Module 2 Military SCOPE of Pain: Safe and Competent Opioid Prescribing For Providers Working with Veterans and Military Service Personnel Information Video CME Post-Test Evaluation
  1. Video Modules
  2. Module 1 Case Studies In Practice: Applying Principles
    of Safe Opioid Prescribing
    Information Introduction Cases Case I Case II Case III Certification CME Post-Test Evaluation
  3. Module 2 Complex Convrs. High Dose Opioids
    & Illicit Drug Use
    Information Introduction Cases Case I-A Case I-B Case II Certification CME Post-Test Evaluation
  4. Module 3 Using the PDMP PMP Questionable Activity Information Introduction Cases Case I Case II Certification CME Post-Test Evaluation

Daniel P. Alford, MD, MPH, FACP (Course Director)
Professor of Medicine
Boston University School of Medicine
Boston Medical Center
dan.alford@bmc.org

Dr. Daniel Alford is Professor of Medicine at Boston University School of Medicine and is on staff in the Section of General Internal Medicine, Clinical Addiction Research and Education Unit at Boston Medical Center (BMC). He is certified in Addiction Medicine by the American Board of Addiction Medicine. He serves as the medical director of the Massachusetts Screening, Brief Intervention, Referral and Treatment (MASBIRT) program and the BMC Office-based Opioid Treatment program. He serves as a national mentor for the SAMHSA Physician Clinical Support Systems (PCSS) for buprenorphine and clinical expert for the PCSS for methadone in the treatment of pain and opioid addiction. He co-chairs the American Society of Addiction Medicine (ASAM) committees on Opioid Agonist Treatment and Buprenorphine Training. He directs the NIDA funded Chief Resident Immersion Training Program - Addiction Medicine: Improving Clinical and Teaching Skills for Generalists. He chairs the Society of General Internal Medicine (SGIM) Pain Medicine Interest Group and is on the executive board of the Association of Medical Education in Research in Substance Abuse (AMERSA). He serves on the Prescription Monitoring Program Advisory Council of the Massachusetts Department of Public Health. His clinical, educational and research focus is on the treatment of opioid dependence, the safe and effective use of opioids for chronic pain and the interplay between pain and addiction.

Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that he does not discuss unlabeled/investigational uses of a commercial product.

 

Jeffrey Baxter, MD
Assistant Professor
Department of Family Medicine and Community Health
University of Massachusetts Medical School
jeff.baxter@umassmed.edu

Jeffrey Baxter, MD is an assistant professor in the Department of Family Medicine at the University of Massachusetts Medical School.  He is board certified in Family Medicine and Addiction Medicine and is the medical director for the Spectrum Health Systems network of methadone maintenance programs and the UMASS Community Health Link adult and adolescent detoxification units in Massachusetts.  He also consults for the UMASS Correctional Health Program and the Massachusetts State Department of Corrections on addiction treatment issues for incarcerated populations.

Dr. Baxter’s areas of clinical and educational specialty include the treatment of opiate dependence and the interface between chronic pain and addiction.  He is a mentor with SAMHSA funded Physician Clinical Support Service (PCSS), a nationwide network which provides clinical support to clinicians offering buprenorphine treatment and pain management with opioid medications.  He is also working with the NIDA Centers of Excellence in Physician Information Program (NIDA-CoE) developing curricular materials to educate medical providers and trainees in the safer use of opioid medications in the treatment of pain.

Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that he does not discuss unlabeled/investigational uses of a commercial product.

 

Donna Beers BSN, RN-BC, CARN

Donna Beers has over 25 years' experience in clinical, research, inpatient, and outpatient substance abuse and mental health treatment settings. In addition to having her certification in addictions nursing, Ms. Beers is also board certified in pain management nursing Ms. Beers currently works at Boston Medical Center on a NIH-funded randomized control trial looking at improving the safety of opioid prescribing practices in Primary Care.   She has extensive experience providing overdose prevention education and naloxone distribution, and well as working with out-of-treatment medically hospitalized drug users.

Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that she does not discuss unlabeled/investigational uses of a commercial product.

 

Jeffrey Bratberg, PharmD, BCPS

Jeffrey Bratberg is Clinical Professor at the University of Rhode Island College of Pharmacy in Kingston, RI.  His research interests include expanding pharmacists' roles in public health, particularly in emergency preparedness, HIV and other disease surveillance, prevention of opioid drug overdose and death, and expanding immunization practices.  He is helping to implement the Rhode Island Collaborative Pharmacy Practice Agreement for naloxone (CPAN), an effort including the RI Department of Health and every Rhode Island Walgreens and CVS pharmacy, totaling 88 pharmacies and nearly 400 pharmacists.   He has worked on quantitative and qualitative studies on the use of pharmacists and pharmacies in public health initiatives, particularly as an expert consultant on a grant examining pharmacy staff attitudes and experiences of selling over the counter syringes to injection drug users.  A former president of the Rhode Island Pharmacists Association (RIPA), he is well acquainted with the challenges facing community pharmacists and pharmacies regarding opioid dispensing and addiction.

Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that he does not discuss unlabeled/investigational uses of a commercial product.

 

Sheila E. Chapman, MD
Assistant Professor of Medicine
Boston Medical Center
Boston University School of Medicine
sheila.chapman@bmc.org

Dr. Sheila Chapman is an Assistant Professor of Medicine at Boston University School of Medicine and a clinician educator practicing at Boston Medical Center. She is a faculty member of Boston Medical Center’s Section of General Internal Medicine and of the Clinical Addiction Research and Education (CARE) Unit. She practices as well in the Boston Public Health Commission’s Opioid Treatment Program and has a particular interest and expertise in the management of pregnant women with opioid dependence.

Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that she does not discuss unlabeled/investigational uses of a commercial product.

 

Phoebe Cushman, MD
Instructor of Medicine
Boston University School of Medicine
Boston Medical School

Dr. Phoebe Cushman is a postdoctoral research fellow and General Internal Medicine physician at Boston University whose research, teaching, and clinical work focus on opioids, chronic pain, and addiction. She is currently finishing her thesis toward a M.S. in Health Services Research at B.U. School of Public Health.  Prior to starting her research fellowship, Dr. Cushman worked as a primary care physician for 9 years,  primarily in community health center settings.

Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that she does not discuss unlabeled/investigational uses of a commercial product.


 

Corey Davis, JD, MSPH
Deputy Director
The Network for Public Health Law

Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that she does not discuss unlabeled/investigational uses of a commercial product.

 

Traci C. Green, PhD, MSc
Emergency Medicine Department
Rhode Island Hospital

Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that she does not discuss unlabeled/investigational uses of a commercial product.

 

Jane Liebschutz, MD, MPH, FACP
Associate Professor of Medicine and Social and Behavioral Sciences
Boston University Schools of Medicine and Public Health
Boston Medical Center
jane.liebschutz@bmc.org

Dr. Liebschutz is a primary care internist, preventive medicine physician, researcher and educator at Boston University School of Medicine and Boston Medical Center.  She is Director of the General Internal Medicine Fellowship and Preventive Medicine Residency programs at Boston University School of Medicine.

Her primary areas of expertise and research involve the health impact of violence, including the intersection with substance use disorders, health care utilization, chronic pain, and the patient doctor relationship. Another area of interest includes use of opiates for chronic pain.  She uses both qualitative and quantitative research methods.

Her research and educational endeavors have been supported by NIH, the Robert Wood Johnson foundation, the American Cancer Society, Substance Abuse-Mental Health Services Administration, and the Health Resources Service Administration.

Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that she does not discuss unlabeled/investigational uses of a commercial product.

 

John A. Renner, Jr., MD
Professor of Psychiatry
Boston University School of Medicine
Associate Chief of Psychiatry, VA Boston Healthcare System
john.renner@va.gov

Dr. Renner is Professor of Psychiatry, Boston University School of Medicine, and Associate Chief of Psychiatry for the Veterans Administration (VA) Boston Healthcare System. He graduated from Yale University and Case University School of Medicine and completed his psychiatric residency at the Tufts-New England Medical Center.  In 1969, Dr. Renner served as a psychiatrist with the US Navy in Vietnam, and since 1979 he has been working with veterans at the Boston VA.  In addition to his clinical activities at the VA, he is Associate Director of the Boston University Medical Center General Psychiatry Residency Program and Director of their Addiction Psychiatry Residency.  Dr. Renner has written and lectured extensively on the treatment of alcoholism and drug addiction.  He is a former chair of the American Psychiatric Association Corresponding Committee on Training and Education in Addiction Psychiatry and is currently Chairperson of the APA Council on Adult Psychiatry and Chair of the APA Expert Advisory Panel on Addiction Psychiatry.  Dr. Renner is currently working on a book on buprenorphine for the American Psychiatric Press, Inc.  He is a Secretary of the Board of Directors of the American Academy of Addiction Psychiatry, and is also a member of the Data Safety Monitoring Board for the Clinical Trials Network of the National Institute on Drug Abuse, a member of the Clinical Advisory Committee of the Physician Health Service of the Massachusetts Medical Society, a Consultant to the Department of Psychiatry, Massachusetts General Hospital, and a member of the faculty of the Harvard Medical School Division on Addictions.

Faculty member holds stock in Johnson & Johnson. Faculty member indicates that he does discuss the off label use of buprenorphine/naloxone for pain, and parzosin for PTSD related nightmares.

 

Alexander Y. Walley, MD, MSc
Course Co-Director

Alexander Y. Walley is an Assistant Professor of Medicine at Boston University School of Medicine and a general internist and addiction medicine specialist at Boston Medical Center.  He trained in internal medicine at University of California, San Francisco (UCSF) and was a Chief Resident at San Francisco General Hospital in 2003-2004.  He does clinical and research-related work on the medical complications of substance use, specifically HIV and overdose.  He provides primary care and office-based buprenorphine treatment for HIV patients at Boston Medical Center and methadone maintenance treatment at Community Substance Abuse Centers. He is the medical director for the Massachusetts Department of Public Health's Opioid Overdose Prevention Pilot Program. He is the Program Director of the Boston University Addiction Medicine Fellowship program.

Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that he does not discuss unlabeled/investigational uses of a commercial product.